Tempus AI (NASDAQ:TEM) Rating Lowered to Neutral at JPMorgan Chase & Co.

Tempus AI (NASDAQ:TEM) was downgraded by research analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday, Marketbeat reports. They presently have a $55.00 target price on the stock, up from their previous target price of $50.00. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 20.94% from the company’s previous close.

Several other analysts have also recently commented on the stock. Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Guggenheim started coverage on shares of Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Wolfe Research started coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Bank of America lifted their target price on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Finally, TD Cowen reaffirmed a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $59.27.

Tempus AI Stock Performance

TEM stock opened at $69.57 on Tuesday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $91.45. The firm’s 50-day moving average is $50.88 and its 200 day moving average is $52.03. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Tempus AI (NASDAQ:TEM) last released its earnings results on Monday, February 24th. The company reported ($0.33) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.18). On average, analysts anticipate that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other news, Director Jennifer A. Doudna sold 1,320 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $90.00, for a total transaction of $118,800.00. Following the sale, the director now owns 36,011 shares of the company’s stock, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Lefkofsky sold 80,003 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $85.78, for a total transaction of $6,862,657.34. Following the sale, the chief executive officer now directly owns 5,049,460 shares in the company, valued at $433,142,678.80. This represents a 1.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,583,467 shares of company stock valued at $130,542,311 over the last 90 days.

Hedge Funds Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently bought and sold shares of TEM. International Assets Investment Management LLC boosted its position in shares of Tempus AI by 141,400.0% during the 3rd quarter. International Assets Investment Management LLC now owns 70,750 shares of the company’s stock worth $4,004,000 after purchasing an additional 70,700 shares in the last quarter. Janney Capital Management LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth $385,000. Vestor Capital LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth $153,000. ARK Investment Management LLC boosted its position in shares of Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after purchasing an additional 1,855,459 shares in the last quarter. Finally, Sigma Planning Corp acquired a new position in shares of Tempus AI during the 3rd quarter worth $1,323,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.